Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v4-FR | |
---|---|---|
Language | English | French |
Date Updated | 2018-01-01 | 2017-04-04 |
Drug Identification Number | 02344327 | 02344327 |
Brand name | CLINOLEIC 20% | CLINOLEIC 20% |
Common or Proper name | Refined Olive Oil and Refined Soybean Oil Lipid Emulsion | Refined Olive Oil and Refined Soybean Oil Lipid Emulsion |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | SOYBEAN OIL OLIVE OIL | SOYBEAN OIL OLIVE OIL |
Strength(s) | 4% 16% | 4% 16% |
Dosage form(s) | EMULSION | EMULSION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 1000mL | 1000mL |
ATC code | B05BA | B05BA |
ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2017-12-31 | 2017-09-01 |
Actual discontinuation date | 2017-12-31 | |
Remaining supply date | 2017-09-01 | 2017-09-01 |
Discontinuation status | Discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | We have finished producing this product and are simply selling out the remainder of our stock before discontinuing the code. We anticipate based on current usage that we will be out of stock by Sept 1st 2017 | We have finished producing this product and are simply selling out the remainder of our stock before discontinuing the code. We anticipate based on current usage that we will be out of stock by Sept 1st 2017 |
Health Canada comments |